http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008062470-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7085a863f2937c1b2da5d268b1dfd271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80445f391640befdfeb7f03393b54eea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44367c7b17bf07d2d403f117a3fe1a97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97d493a7f3c5b6bff339ceccdcc0b1d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2231726470262524eaca9ab4eeccdf7a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2007-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8918f1d2cf1e5057dbdd3b7a227ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_845529e5dc48528e94fb840550dd38c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef5a44e7e8ae5cf1e820914c49617a0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd3e3f8c352af68fde447f1228d7f5d
publicationDate 2009-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008062470-A3
titleOfInvention Stabilized controlled release dosage form of gliclazide
abstract The present invention is directed to stabilized controlled release dosage form of Gliclazide, exhibiting pH independent release profile over a wide range, having one or more release controlling polymer and free from saccharide component and optionally free from binder and process for preparing such dosage form.
priorityDate 2006-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006061697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005009412-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006104401-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127546735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406572

Total number of triples: 32.